About Radiopharmaceutical Therapy

Radiopharmaceutical therapy (also called targeted radionuclide therapy, molecular radiotherapy, or RPT) involves a radioactive drug compound that seeks and destroys cancer cells.

Most radiopharmaceuticals consist of a small amount of radioactive material — called a radionuclide — combined with a cell-targeting molecule. When injected into the patient’s bloodstream, the radiopharmaceutical travels to and delivers radiation directly to disease sites. Because it is highly selective in its ability to damage cancerous cells while limiting radiation exposure to healthy tissue, molecular therapy is known as a targeted therapy. 

Patient Fact Sheets

SNMMI has developed fact sheets and guidelines to help you better understand your nuclear medicine treatment.

Therapy Procedures

Nuclear medicine radiopharmaceutical therapy offers safe, effective, targeted treatments for several types of disease.
Learn more about these radiopharmaceutical therapy procedures:

Therapy Infographic

Learn more about cancer treatment using radiopharmaceutical therapy.

Click the image to enlarge.

Learn More About Neuroendocrine Tumor (NET) Therapies

         
Current Imaging and Therapy of NETs
with Nuclear Medicine
Erik Mittra, MD, PhD
  PRRT Patient Experience
Linda "Lindy" Gardner, BSN, RN
  Future of PRRT and Molecular Imaging for NETs:
What is on the Horizon?
Richard Baum, MD, PhD
  PRRT: Now, Later, Never?
George Fisher, MD, PhD 

Learn More About Thyroid Cancer Therapies


   
   
 
What to Expect: Radioiodine Therapy   The Role of Radioiodine in
Thyroid Cancer Treatment
  I-131 Therapy for Thyroid Cancer   Thyroid Imaging and Therapy